Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does inflammation contribute to thrombotic events?

C T Esmon1

  • 1Oklahoma Medical Research Foundation, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Okla., USA. Charles-Esmon@omrf.ouhsc.edu

Haemostasis
|March 17, 2001
PubMed
Summary

Inflammation can promote blood clotting through various mechanisms, but it rarely causes thrombosis alone. Multiple simultaneous factors, like reduced blood flow and inhibited anticoagulation, are typically required for inflammation to trigger clot formation in vivo.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Group V secretory phospholipase A2 impairs endothelial protein C receptor-dependent protein C activation and accelerates thrombosis in vivo.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Factor VIIa binding to endothelial cell protein C receptor protects vascular barrier integrity in vivo.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis).

Journal of thrombosis and haemostasis : JTH·2012
Same author

Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

Journal of thrombosis and haemostasis : JTH·2012
Same author

Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.

Journal of thrombosis and haemostasis : JTH·2012

Area of Science:

  • Biochemistry
  • Immunology
  • Hematology

Background:

  • Inflammation involves mediators like endotoxin and TNF-alpha, which can initiate the coagulation cascade.
  • Complement system activation and inflammatory cytokines (e.g., IL-6) can amplify clotting and suppress fibrinolysis.
  • Previous research suggests inflammation potentiates blood clotting through various molecular pathways.

Purpose of the Study:

  • To investigate the role of inflammation in triggering clinically relevant thrombus formation in vivo.
  • To determine the conditions under which inflammatory mediators can promote clot deposition.

Main Methods:

  • Review of recent studies on inflammation and coagulation.
  • Analysis of clinical data from cancer patients treated with TNF-alpha.

Related Experiment Videos

  • Examination of primate studies investigating inflammatory mediators and clot formation.

    • Main Results:

    • Inflammatory mediators can initiate and amplify coagulation and suppress fibrinolysis.
    • TNF-alpha administration in cancer patients did not commonly lead to thrombosis despite hypercoagulability.
    • Inflammatory mediators promote clot deposition in vivo primarily when combined with reduced blood flow and inhibited anticoagulant pathways.

    Conclusions:

    • Inflammation alone is insufficient to cause clinically significant thrombosis.
    • The development of thrombosis typically requires multiple simultaneous injurious events, including inflammation, altered blood flow, and impaired anticoagulation.